HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lapo Alinari Selected Research

Disease Progression

4/2021Integration of Metabolomics and Gene Expression Profiling Elucidates IL4I1 as Modulator of Ibrutinib Resistance in ABC-Diffuse Large B Cell Lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lapo Alinari Research Topics

Disease

25Lymphoma (Lymphomas)
01/2024 - 08/2002
25Neoplasms (Cancer)
10/2023 - 10/2005
19Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2024 - 01/2009
14Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2024 - 08/2002
9B-Cell Lymphoma (Lymphoma, B Cell)
01/2024 - 12/2002
9Hodgkin Disease (Hodgkin's Disease)
02/2023 - 08/2002
9Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2022 - 03/2005
6Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 04/2018
5B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2023 - 11/2010
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
06/2011 - 07/2004
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
09/2007 - 05/2005
3Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
09/2007 - 09/2005
3Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
10/2006 - 05/2003
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2022 - 01/2021
2Genetic Translocation (Chromosomal Translocation)
12/2018 - 02/2012
2T-Cell Lymphoma (Lymphoma, T Cell)
04/2010 - 05/2005
2Pathologic Complete Response
06/2006 - 07/2004
2Mycosis Fungoides
12/2005 - 09/2005
1Neoplasm Metastasis (Metastasis)
12/2022
1Disease Progression
04/2021
1Atrial Fibrillation
04/2019
1Infections
04/2019
1Headache (Headaches)
04/2019
1Hemorrhage
04/2019
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2017
1Epstein-Barr Virus Infections
09/2016
1Glioblastoma (Glioblastoma Multiforme)
03/2014
1Oral Ulcer (Mouth Ulcer)
12/2012
1Breast Neoplasms (Breast Cancer)
09/2012
1B-Cell Leukemia (Leukemia, B Cell)
09/2012
1Leukemia
09/2012

Drug/Important Bio-Agent (IBA)

9Rituximab (Mabthera)FDA Link
01/2022 - 09/2003
8ibrutinibIBA
01/2024 - 04/2019
5Monoclonal AntibodiesIBA
09/2023 - 11/2010
5Proteins (Proteins, Gene)FDA Link
12/2022 - 03/2005
5Cyclin D1IBA
01/2020 - 06/2010
5Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2009 - 10/2004
4milatuzumabIBA
09/2023 - 04/2011
4Agammaglobulinaemia Tyrosine KinaseIBA
01/2023 - 04/2019
4fludarabineIBA
12/2005 - 05/2004
3Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
01/2021 - 03/2014
3Arginine (L-Arginine)FDA Link
01/2021 - 04/2015
3Fingolimod Hydrochloride (FTY720)FDA Link
03/2012 - 06/2010
3Bortezomib (Velcade)FDA Link
06/2011 - 09/2007
3IfosfamideFDA LinkGeneric
11/2008 - 08/2002
3Etoposide (VP 16)FDA LinkGeneric
11/2008 - 08/2002
3Epirubicin (Ellence)FDA LinkGeneric
11/2008 - 08/2002
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2005 - 05/2004
2Chimeric Antigen ReceptorsIBA
03/2024 - 09/2023
2NivolumabIBA
02/2023 - 01/2017
2TransducinIBA
12/2022 - 11/2021
2Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 01/2022
2EnzymesIBA
01/2021 - 04/2015
2ChromatinIBA
01/2021 - 03/2014
2pembrolizumabIBA
04/2018 - 09/2016
2LigandsIBA
09/2016 - 09/2009
1erdafitinibIBA
10/2023
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
10/2023
1Antigen-Antibody Complex (Immune Complex)IBA
01/2023
1Positive Transcriptional Elongation Factor BIBA
01/2023
1Brentuximab VedotinIBA
01/2023
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
01/2023
1Transcription Factors (Transcription Factor)IBA
12/2022
1Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
12/2022
1CateninsIBA
12/2022
1Co-Repressor ProteinsIBA
12/2022
1Dihydroorotate DehydrogenaseIBA
09/2022
1fms-Like Tyrosine Kinase 3IBA
09/2022
1gilteritinibIBA
09/2022
1NVP-BKM120IBA
01/2022
1Nicotinamide PhosphoribosyltransferaseIBA
01/2021
1SNX-5422IBA
01/2021
1KPT-9274IBA
01/2021
1Histone Deacetylases (Histone Deacetylase)IBA
01/2021
1selinexorIBA
11/2020
1zanubrutinibIBA
01/2020
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Immune Checkpoint ProteinsIBA
10/2019
1acalabrutinibIBA
04/2019
1Phosphotransferases (Kinase)IBA
12/2018
1Oncogene Proteins (Oncogene Protein)IBA
12/2018
1PLX51107IBA
01/2018
1Immune Checkpoint InhibitorsIBA
01/2017
1Histones (Histone)IBA
04/2015
1Protein Synthesis InhibitorsIBA
09/2012
1silvestrolIBA
09/2012
1Cyclin DIBA
09/2012
1CyclinsIBA
09/2012
1SphingosineIBA
03/2012
1NF-kappa B (NF-kB)IBA
02/2012
1Phosphatidylinositols (Phosphatidylinositol)IBA
02/2012

Therapy/Procedure

30Therapeutics
03/2024 - 08/2002
11Drug Therapy (Chemotherapy)
12/2018 - 08/2002
3Salvage Therapy
06/2006 - 02/2004
3Radiotherapy
10/2004 - 12/2002
2Stem Cell Transplantation
06/2016 - 11/2008
2Autologous Transplantation
02/2004 - 05/2003
1Hematopoietic Stem Cell Transplantation
01/2023
1Immunotherapy
01/2023